Literature DB >> 20460529

Carcinomas contain a matrix metalloproteinase-resistant isoform of type I collagen exerting selective support to invasion.

Elena Makareeva1, Sejin Han, Juan Carlos Vera, Dan L Sackett, Kenn Holmbeck, Charlotte L Phillips, Robert Visse, Hideaki Nagase, Sergey Leikin.   

Abstract

Collagen fibers affect metastasis in two opposing ways, by supporting invasive cells but also by generating a barrier to invasion. We hypothesized that these functions might be performed by different isoforms of type I collagen. Carcinomas are reported to contain alpha1(I)(3) homotrimers, a type I collagen isoform normally not present in healthy tissues, but the role of the homotrimers in cancer pathophysiology is unclear. In this study, we found that these homotrimers were resistant to all collagenolytic matrix metalloproteinases (MMP). MMPs are massively produced and used by cancer cells and cancer-associated fibroblasts for degrading stromal collagen at the leading edge of tumor invasion. The MMP-resistant homotrimers were produced by all invasive cancer cell lines tested, both in culture and in tumor xenografts, but they were not produced by cancer-associated fibroblasts, thereby comprising a specialized fraction of tumor collagen. We observed the homotrimer fibers to be resistant to pericellular degradation, even upon stimulation of the cells with proinflammatory cytokines. Furthermore, we confirmed an enhanced proliferation and migration of invasive cancer cells on the surface of homotrimeric versus normal (heterotrimeric) type I collagen fibers. In summary, our findings suggest that invasive cancer cells may use homotrimers for building MMP-resistant invasion paths, supporting local proliferation and directed migration of the cells whereas surrounding normal stromal collagens are cleaved. Because the homotrimers are universally secreted by cancer cells and deposited as insoluble, MMP-resistant fibers, they offer an appealing target for cancer diagnostics and therapy. Copyright 2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460529      PMCID: PMC2880213          DOI: 10.1158/0008-5472.CAN-09-4057

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Collagen from the osteogenesis imperfecta mouse model (oim) shows reduced resistance against tensile stress.

Authors:  K Misof; W J Landis; K Klaushofer; P Fratzl
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Type I and I-trimer collagens as substrates for breast carcinoma cells in culture. Effect on growth rate, morphological appearance and actin organization.

Authors:  R Schillaci; C Luparello; S Minafra
Journal:  Eur J Cell Biol       Date:  1989-02       Impact factor: 4.492

Review 3.  Biology and biochemistry of proteinases in tumor invasion.

Authors:  P Mignatti; D B Rifkin
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

4.  Two cell lines from bone marrow that differ in terms of collagen synthesis, osteogenic characteristics, and matrix mineralization.

Authors:  D R Diduch; M R Coe; C Joyner; M E Owen; G Balian
Journal:  J Bone Joint Surg Am       Date:  1993-01       Impact factor: 5.284

5.  Coordinate modulation of melanogenesis and type I trimer collagen secretion by type I collagen substratum during reversible conversion between melanotic and amelanotic cells in mouse B16 melanoma.

Authors:  A U Ishikoh; A Hayashi; I Tokimitsu; S Tajima; T Nishikawa
Journal:  J Biochem       Date:  1994-09       Impact factor: 3.387

6.  Direct adhesion to type I and homotrimer collagens by breast carcinoma and embryonic epithelial cells in culture: a comparative study.

Authors:  G Ghersi; A M La Fiura; S Minafra
Journal:  Eur J Cell Biol       Date:  1989-12       Impact factor: 4.492

7.  Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.

Authors:  S D Chipman; H O Sweet; D J McBride; M T Davisson; S C Marks; A R Shuldiner; R J Wenstrup; D W Rowe; J R Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Purification and characterization of collagens from rat fibrosarcoma induced by 3-methylcholanthrene.

Authors:  R Asokan; R Puvanakrishnan; L V Ravichandran; V Kokila; G K Reddy; S C Dhar
Journal:  Mol Cell Biochem       Date:  1993-04-21       Impact factor: 3.396

9.  A comparison of spreading and motility behaviour of 8701-BC breast carcinoma cells on type I, I-trimer and type V collagen substrata. Evidence for a permissive effect of type I-trimer collagen on cell locomotion.

Authors:  C Luparello; P Sheterline; I Pucci-Minafra; S Minafra
Journal:  J Cell Sci       Date:  1991-09       Impact factor: 5.285

10.  A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling.

Authors:  X Liu; H Wu; M Byrne; J Jeffrey; S Krane; R Jaenisch
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

View more
  45 in total

1.  Molecular mechanism of force induced stabilization of collagen against enzymatic breakdown.

Authors:  Shu-Wei Chang; Brendan P Flynn; Jeffrey W Ruberti; Markus J Buehler
Journal:  Biomaterials       Date:  2012-03-06       Impact factor: 12.479

2.  Conformational dynamics accompanying the proteolytic degradation of trimeric collagen I by collagenases.

Authors:  Arjun S Adhikari; Emerson Glassey; Alexander R Dunn
Journal:  J Am Chem Soc       Date:  2012-08-01       Impact factor: 15.419

3.  Pulse-chase analysis of procollagen biosynthesis by azidohomoalanine labeling.

Authors:  Lynn S Mirigian; Elena Makareeva; Sergey Leikin
Journal:  Connect Tissue Res       Date:  2014-09-22       Impact factor: 3.417

4.  Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

Authors:  Christopher Y Kang; Jonathan Wang; Dierdre Axell-House; Pranay Soni; Mon-Li Chu; Galina Chipitsyna; Konrad Sarosiek; Jocelyn Sendecki; Terry Hyslop; Mazhar Al-Zoubi; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

5.  Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer.

Authors:  Hwyda Arafat; Melissa Lazar; Khalifa Salem; Galina Chipitsyna; Qiaoke Gong; Te-Cheng Pan; Rui-Zhu Zhang; Charles J Yeo; Mon-Li Chu
Journal:  Surgery       Date:  2011-06-30       Impact factor: 3.982

Review 6.  Matrix metalloproteinase collagenolysis in health and disease.

Authors:  Sabrina Amar; Lyndsay Smith; Gregg B Fields
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-26       Impact factor: 4.739

Review 7.  Interstitial collagen catabolism.

Authors:  Gregg B Fields
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

8.  Osteoblast Malfunction Caused by Cell Stress Response to Procollagen Misfolding in α2(I)-G610C Mouse Model of Osteogenesis Imperfecta.

Authors:  Lynn S Mirigian; Elena Makareeva; Edward L Mertz; Shakib Omari; Anna M Roberts-Pilgrim; Arin K Oestreich; Charlotte L Phillips; Sergey Leikin
Journal:  J Bone Miner Res       Date:  2016-04-13       Impact factor: 6.741

9.  Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases.

Authors:  Sejin Han; Elena Makareeva; Natalia V Kuznetsova; Angela M DeRidder; Mary Beth Sutter; Wolfgang Losert; Charlotte L Phillips; Robert Visse; Hideaki Nagase; Sergey Leikin
Journal:  J Biol Chem       Date:  2010-05-12       Impact factor: 5.157

10.  Kuskokwim syndrome, a recessive congenital contracture disorder, extends the phenotype of FKBP10 mutations.

Authors:  Aileen M Barnes; Geraldine Duncan; Maryann Weis; William Paton; Wayne A Cabral; Edward L Mertz; Elena Makareeva; Michael J Gambello; Felicitas L Lacbawan; Sergey Leikin; Andrzej Fertala; David R Eyre; Sherri J Bale; Joan C Marini
Journal:  Hum Mutat       Date:  2013-07-08       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.